{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"page_content": "and Other Comprehensive Income of the associate or Joint Venture. Distributions received from an associate or \na Joint Venture reduce the carrying amount of the investment. When the Group\u2019s share of losses of an associate \nor a Joint Venture exceeds the Group\u2019s interest in that associate or Joint Venture (which includes any long-term \ninterests that, in substance, form part of the Group\u2019s net investment in the associate or Joint Venture); the Group \ndiscontinues recognising its share of further losses. Additional losses are recognised only to the extent that the \nGroup has incurred legal or constructive obligations or made payments on behalf of the associate or Joint Venture.\n On acquisition of the investment in an Associate or a Joint Venture, any excess of the cost of the investment \nover the Group\u2019s share of the net fair value of the identifiable assets and liabilities of the investee is recognised \nas goodwill, which is included within the carrying amount of the investment. Any excess of the Group\u2019s share of \nthe net fair value of the identifiable assets and liabilities over the cost of the investment, after reassessment, is \nrecognised directly in equity as capital reserve.\n After application of the equity method of accounting, the Group determines whether there is any objective \nevidence of the impairment as a result of one or more events that occurred after the initial recognition of the \nnet investment in an associate or Joint Venture and that event (or events) has an impact on the estimated future \ncash flows from the net investment that can be reliably estimated. If there exists such an objective evidence \nof impairment, then it is necessary to recognise impairment loss with respect to the Group\u2019s investment in an \nAssociate or Joint Venture. \n When necessary, the entire carrying amount of the investment (including goodwill) is tested for impairment in", "metadata": {"source": "/content/drive/MyDrive/pidilite/Annual-Report-2022-2023.pdf", "page": 201}, "type": "Document"}}